Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Immunol ; 38(5): 1225-30, 2008 May.
Article in English | MEDLINE | ID: mdl-18389477

ABSTRACT

IL-10 is a potent anti-inflammatory cytokine interfering with antigen presentation by inducing the intracellular sequestration of MHC class II (MHC-II) molecules. Here we studied the contribution of membrane-associated RING-CH (MARCH) ubiquitin ligase family members to the IL-10-induced down-regulation of MHC-II molecules. We found that MARCH1 and MARCH8 proteins are the most potent family members for the down-regulation of MHC-II surface expression in transfected cells, but only MARCH1 mRNA expression is strongly induced by IL-10 in human primary monocytes. We detected mono- and poly-ubiquitinated forms of MHC-II molecules both in IL-10-treated monocytes and in cells transfected with MARCH1. We also show direct interaction between MHC-II and MARCH1 molecules in co-immunoprecipitation assays. Finally, we found that siRNA-mediated knockdown of MARCH1 reverses IL-10-induced MHC-II down-regulation in primary monocytes. Thus, the immunosuppressive effect of IL-10 on antigen presentation is mediated through induced expression of MARCH1.


Subject(s)
HLA-D Antigens/metabolism , Interleukin-10/physiology , Monocytes/metabolism , Ubiquitin-Protein Ligases/physiology , B7-2 Antigen/metabolism , Down-Regulation , Gene Expression/drug effects , HLA-DR Antigens/metabolism , HeLa Cells , Humans , Interferon-gamma/pharmacology , Interleukin-10/pharmacology , Membrane Proteins/metabolism , Monocytes/drug effects , Nuclear Proteins/genetics , Protein Binding , RNA, Small Interfering/genetics , Trans-Activators/genetics , Ubiquitin-Protein Ligases/genetics , Ubiquitination/immunology
2.
Blood ; 102(12): 3989-97, 2003 Dec 01.
Article in English | MEDLINE | ID: mdl-12920025

ABSTRACT

To study epigenetic regulation of the human beta-globin locus during hematopoiesis, we investigated patterns of histone modification and chromatin accessibility along this locus in hematopoietic progenitor cells (HPCs) derived from both humans and transgenic mice. We demonstrate that the developmentally related activation of human beta-like globin genes in humans and transgenic mice HPCs is preceded by a wave of gene-specific histone H3 hyperacetylation and K4 dimethylation. In erythroid cells, expression of beta-like globin genes is associated with histone hyperacetylation along these genes and, surprisingly, with local deacetylation at active promoters. We also show that endogenous mouse beta major and human beta-like genes are subject to different epigenetic control mechanisms in HPCs. This difference is likely due to intrinsic properties of the human beta-globin locus since, in transgenic mice, this locus is epigenetically regulated in the same manner as in human HPCs. Our results suggest that a defined pattern of histone H3 acetylation/dimethylation is important for specific activation of human globin promoters during development in human and transgenic HPCs. We propose that this transient acetylation/dimethylation is involved in gene-specific potentiation in HPCs (ie, before extensive chromatin remodeling and transcription take place in erythroid cells).


Subject(s)
Epigenesis, Genetic , Gene Expression Regulation, Developmental , Globins/biosynthesis , Hematopoietic Stem Cells/metabolism , Transcriptional Activation , Acetylation , Animals , Bone Marrow Cells , Hematopoiesis , Histones/genetics , Histones/metabolism , Humans , Methylation , Mice , Mice, Transgenic , Promoter Regions, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL
...